Definitive Healthcare (NASDAQ:DH) Issues Q4 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its fourth quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.07 for the period, compared to the consensus estimate of $0.06. The company issued revenue guidance of $60-$61 million, compared to the consensus revenue estimate of $60.33 million. Definitive Healthcare also updated its FY 2024 guidance to 0.340-0.350 EPS.

Analyst Upgrades and Downgrades

Several analysts have issued reports on DH shares. BTIG Research assumed coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price objective for the company. Deutsche Bank Aktiengesellschaft cut their price objective on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. JPMorgan Chase & Co. lowered shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $7.00 to $5.00 in a research note on Wednesday, July 31st. Robert W. Baird reduced their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Tuesday, August 6th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $5.81.

Definitive Healthcare Stock Performance

NASDAQ DH traded up $0.01 during midday trading on Thursday, hitting $4.31. 543,715 shares of the company traded hands, compared to its average volume of 748,693. The company has a quick ratio of 2.40, a current ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62. The company’s 50-day simple moving average is $4.38 and its 200-day simple moving average is $5.04.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. The company had revenue of $63.70 million for the quarter, compared to the consensus estimate of $63.19 million. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.08 earnings per share. Equities analysts anticipate that Definitive Healthcare will post 0.07 EPS for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.